about
A dimensional and categorical architecture for the classification of psychotic disordersExploring the borders of the schizoaffective spectrum: a categorical and dimensional approachInsight dimensions and cognitive function in psychosis: a longitudinal study.Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study.How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment.Premorbid personality and insight in first-episode psychosis.Dermatoglyphic anomalies and neurocognitive deficits in sibling pairs discordant for schizophrenia spectrum disorders.The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients.Psychopathological assessment of schizophrenia: relevance for classification.Testing the hypothesis that formal thought disorders are severe mood disorders.Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.Cycloid psychosis.Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in PsychosisCycloid psychosis: an examination of the validity of the concept.A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.Familiality of Psychotic Disorders: A Polynosologic Study in Multiplex Families.Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorderCharacterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.Controversies surrounding the diagnosis of schizophrenia and other psychoses.Thought disorder in schizophrenia. Testing models through confirmatory factor analysis.Eugen Bleuler and the schizophrenias: 100 years after.Going Beyond Classic Descriptions to Future Phenomenology of Schizophrenia.Modelling gene-environment interaction in first episodes of psychosis.When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain.Lifetime psychopathological dimensions, cognitive impairment and functional outcome in psychosis.Duration of untreated psychotic illness: the role of premorbid social support networks.Integrating psychopathological dimensions in functional psychoses: a hierarchical approach.Subjective experiences in schizophrenia: a critical review.Disability in bipolar I disorder: the 36-item World Health Organization Disability Assessment Schedule 2.0.Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.The deficit syndrome of the psychotic illness. A clinical and nosological study.Psychopathological dimensions in schizophrenia.The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone, or olanzapine.Current psychopathological issues in psychosis: towards a phenome-wide scanning approach.DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication.Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.Neuropsychiatric symptoms in Alzheimer's disease and vascular dementia.Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.The relationship between syndromes of the psychotic illness and familial liability to schizophrenia and major mood disorders.Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.
P50
Q24642972-A55CEAD3-C174-44F8-B39C-B81D6B7F7CB6Q28258234-9DF17E38-3D4E-4A92-82A3-5146A23464A6Q33245272-2B8DC14B-BC5A-42C3-BFAA-2AFDCAFCEA93Q34048566-FCAD5028-98FF-409C-B345-9B2163208D6FQ34253313-3610A691-A73D-4E99-BAAA-3994713A775BQ34415919-53147584-44BC-4167-9F01-ECCEDCF2DF74Q34562697-187A151B-100A-43D1-814F-5E88B8CEFC0EQ34707862-3CA5FAFE-8EAA-49B5-BE4E-B025CB5D1A8CQ34994337-40691931-7C0F-4989-B81F-AF3C8CD399B7Q35390430-72FD48F3-54F1-4D55-ABB8-DB9BAD61300FQ36101350-58DE9CA9-0810-4C6A-BE2C-51D94FAAF1FCQ36272486-264A80D4-F0B2-468E-873F-EE25E982EBCCQ36579982-80480BF7-D5D1-4302-A575-B4F2ABE54A57Q36830316-485049B0-F03E-43E7-AD21-5824C2494257Q36852406-9AD091F6-9EE6-4031-941F-C0E396457D44Q36994844-C227EF88-087D-4AEF-810E-805057DB18ADQ37164845-B79FA1AD-E5B3-45A0-8A8B-31D46992195EQ37451422-31DE8254-2B1D-4306-A904-1C2E0DE8FE65Q37615360-CCF07546-EED0-4FB6-8768-49FE69BC655EQ38449377-086A72F4-57FA-4496-9AB2-B59A7F32B7E5Q38756697-31BA02E8-F5A9-4810-89DE-17EE871C767AQ38821385-36C252A1-59CE-4411-A3E4-7A66C9C25170Q38971410-A278E08F-BC46-494E-B7BA-1956AB2117EEQ39131710-2DC8EA97-36CB-4AE8-8D93-9F56D1BF6C09Q39298370-81A3021F-782B-4899-A7A8-4574C2487E36Q39717349-F967832C-21C4-4B56-BD50-E16385C5F728Q40676379-DD294BD3-1661-4DE8-8356-75EE59330A99Q40680511-4CC04498-370B-4204-97EE-2837ACE64354Q41633401-CC27F762-E1C7-4C94-88B5-B4F3564365B4Q42125358-5384C00C-616D-45B3-B2E7-E2623FCA7117Q42629659-8DF1E7CA-322F-418D-B01E-3BBF5683E731Q42672335-D0E2B0F7-742D-4CD7-848D-CC2037F3D7CAQ42686193-369914B1-CA97-49F9-BE7D-D8463D884821Q43192086-BA82A9EA-983C-4231-ABA6-B5BA42B76DFEQ43195416-81DD2AEB-A8CA-4A6D-8839-C71ED4B6A614Q43499365-2EDFFFC4-71DA-4DEE-A6A3-63844FCBB656Q43824549-5A87FD18-E511-475E-8E51-55C000DF2922Q43872699-2AF60CF2-A8D1-41FF-90E6-711ED5E76F15Q44008059-27B848DF-0857-40BE-85A2-F53CB2C27F28Q44400390-AB22B32B-C132-453F-96EC-4FCBD62A0B42
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Manuel J Cuesta
@ast
Manuel J Cuesta
@en
Manuel J Cuesta
@es
Manuel J Cuesta
@nl
type
label
Manuel J Cuesta
@ast
Manuel J Cuesta
@en
Manuel J Cuesta
@es
Manuel J Cuesta
@nl
prefLabel
Manuel J Cuesta
@ast
Manuel J Cuesta
@en
Manuel J Cuesta
@es
Manuel J Cuesta
@nl
P21
P31
P496
0000-0003-0250-5718